TW202419442A - New processes for synthesis of (3-chloro-2-pyridyl)hydrazine - Google Patents
New processes for synthesis of (3-chloro-2-pyridyl)hydrazine Download PDFInfo
- Publication number
- TW202419442A TW202419442A TW112130038A TW112130038A TW202419442A TW 202419442 A TW202419442 A TW 202419442A TW 112130038 A TW112130038 A TW 112130038A TW 112130038 A TW112130038 A TW 112130038A TW 202419442 A TW202419442 A TW 202419442A
- Authority
- TW
- Taiwan
- Prior art keywords
- hydrazine
- phase transfer
- transfer catalyst
- combinations
- mixture
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 84
- XAYCTBDPZIKHCW-UHFFFAOYSA-N (3-chloropyridin-2-yl)hydrazine Chemical compound NNC1=NC=CC=C1Cl XAYCTBDPZIKHCW-UHFFFAOYSA-N 0.000 title claims abstract description 17
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- 239000003444 phase transfer catalyst Substances 0.000 claims description 46
- 239000000203 mixture Substances 0.000 claims description 40
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 30
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 18
- 150000002429 hydrazines Chemical class 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 14
- MAKFMOSBBNKPMS-UHFFFAOYSA-N 2,3-dichloropyridine Chemical compound ClC1=CC=CN=C1Cl MAKFMOSBBNKPMS-UHFFFAOYSA-N 0.000 claims description 14
- 239000003960 organic solvent Substances 0.000 claims description 14
- 229920000136 polysorbate Polymers 0.000 claims description 14
- -1 polyoxyethylene lauryl ethers Polymers 0.000 claims description 13
- 150000007529 inorganic bases Chemical class 0.000 claims description 12
- 235000002639 sodium chloride Nutrition 0.000 claims description 11
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 150000002367 halogens Chemical class 0.000 claims description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- 150000002170 ethers Chemical group 0.000 claims description 9
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 9
- 235000011181 potassium carbonates Nutrition 0.000 claims description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 8
- 150000003983 crown ethers Chemical class 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 7
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical class CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 claims description 6
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 6
- 235000021355 Stearic acid Nutrition 0.000 claims description 6
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 6
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 229940035044 sorbitan monolaurate Drugs 0.000 claims description 6
- 239000008117 stearic acid Substances 0.000 claims description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 6
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 claims description 5
- 239000003125 aqueous solvent Substances 0.000 claims description 5
- 150000002431 hydrogen Chemical class 0.000 claims description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 4
- 229920004890 Triton X-100 Polymers 0.000 claims description 4
- NWELCUKYUCBVKK-UHFFFAOYSA-N pyridin-2-ylhydrazine Chemical compound NNC1=CC=CC=N1 NWELCUKYUCBVKK-UHFFFAOYSA-N 0.000 claims description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 3
- HFTSPKIAXHZROA-UHFFFAOYSA-N (6-chloropyridin-2-yl)hydrazine Chemical compound NNC1=CC=CC(Cl)=N1 HFTSPKIAXHZROA-UHFFFAOYSA-N 0.000 claims description 3
- FILKGCRCWDMBKA-UHFFFAOYSA-N 2,6-dichloropyridine Chemical compound ClC1=CC=CC(Cl)=N1 FILKGCRCWDMBKA-UHFFFAOYSA-N 0.000 claims description 3
- OKDGRDCXVWSXDC-UHFFFAOYSA-N 2-chloropyridine Chemical compound ClC1=CC=CC=N1 OKDGRDCXVWSXDC-UHFFFAOYSA-N 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 239000005639 Lauric acid Substances 0.000 claims description 3
- 235000021314 Palmitic acid Nutrition 0.000 claims description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 3
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical group [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 3
- 239000004147 Sorbitan trioleate Substances 0.000 claims description 3
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 claims description 3
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 claims description 3
- 150000001735 carboxylic acids Chemical class 0.000 claims description 3
- 150000004292 cyclic ethers Chemical class 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 claims description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 150000002334 glycols Chemical class 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 3
- 229920002114 octoxynol-9 Polymers 0.000 claims description 3
- 150000004028 organic sulfates Chemical class 0.000 claims description 3
- 150000002898 organic sulfur compounds Chemical class 0.000 claims description 3
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 claims description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 3
- 239000011736 potassium bicarbonate Substances 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 3
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims description 3
- 229910052939 potassium sulfate Inorganic materials 0.000 claims description 3
- 235000011151 potassium sulphates Nutrition 0.000 claims description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 3
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000001488 sodium phosphate Substances 0.000 claims description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 3
- 235000011152 sodium sulphate Nutrition 0.000 claims description 3
- 235000019337 sorbitan trioleate Nutrition 0.000 claims description 3
- 229960000391 sorbitan trioleate Drugs 0.000 claims description 3
- 239000001589 sorbitan tristearate Substances 0.000 claims description 3
- 235000011078 sorbitan tristearate Nutrition 0.000 claims description 3
- 229960004129 sorbitan tristearate Drugs 0.000 claims description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 3
- 229910000404 tripotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019798 tripotassium phosphate Nutrition 0.000 claims description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 3
- 229910000406 trisodium phosphate Inorganic materials 0.000 claims description 3
- 235000019801 trisodium phosphate Nutrition 0.000 claims description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 3
- 239000002917 insecticide Substances 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 2
- 230000002194 synthesizing effect Effects 0.000 abstract description 2
- PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical class NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 abstract 1
- 239000005886 Chlorantraniliprole Substances 0.000 abstract 1
- 239000005889 Cyantraniliprole Substances 0.000 abstract 1
- PSOVNZZNOMJUBI-UHFFFAOYSA-N chlorantraniliprole Chemical compound CNC(=O)C1=CC(Cl)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl PSOVNZZNOMJUBI-UHFFFAOYSA-N 0.000 abstract 1
- DVBUIBGJRQBEDP-UHFFFAOYSA-N cyantraniliprole Chemical compound CNC(=O)C1=CC(C#N)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl DVBUIBGJRQBEDP-UHFFFAOYSA-N 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 description 4
- 239000000463 material Substances 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 125000001188 haloalkyl group Chemical group 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 2
- FORBXGROTPOMEH-UHFFFAOYSA-N 5-bromo-2-(3-chloropyridin-2-yl)pyrazole-3-carboxylic acid Chemical compound OC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl FORBXGROTPOMEH-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
本揭露關於合成(3-氯-2-吡啶基)肼之新穎方法。藉由本文所揭露之方法製備的化合物可用於製備某些作為殺蟲劑受關注的鄰胺基苯甲醯胺化合物,例如像殺蟲劑氯蟲苯甲醯胺和氰蟲醯胺。The present disclosure relates to novel methods for synthesizing (3-chloro-2-pyridyl)hydrazine. The compounds prepared by the methods disclosed herein can be used to prepare certain amine-aminobenzamide compounds of interest as insecticides, such as the insecticides chloranilamide and cyanamide.
用於生產(3-氯-2-吡啶基)肼的常規方法存在一些工業問題,如危險材料、高成本、相對長之方法步驟及複雜的操作。使用昂貴且難以回收的試劑和有機溶劑係不希望的。Conventional methods for producing (3-chloro-2-pyridyl)hydrazine have some industrial problems, such as hazardous materials, high cost, relatively long process steps and complicated operations. The use of expensive and difficult to recover reagents and organic solvents is undesirable.
此外,一些方法使用危險且不可生物降解的相催化劑。需要另外之方法步驟來處理包含此類相催化劑的流出物流。希望避免使用此類相催化劑。Furthermore, some processes use phase catalysts which are hazardous and non-biodegradable. Additional process steps are required to treat the effluent stream containing such phase catalysts. It is desirable to avoid the use of such phase catalysts.
本揭露提供了可用於製備5-溴-2-(3-氯吡啶-2-基)-2 H-吡唑-3-甲酸及其衍生物之新穎方法。與先前之方法相比,本揭露之方法益處很多,並包括降低成本、消除對混合溶劑分離的需要、減少廢棄物、相對短之方法步驟、簡化操作複雜性、降低過程危險和降低環境問題。 The present disclosure provides novel methods for preparing 5-bromo-2-(3-chloropyridin-2-yl) -2H -pyrazole-3-carboxylic acid and its derivatives. The methods of the present disclosure have many advantages over previous methods and include reduced costs, elimination of the need for mixed solvent separation, reduced waste, relatively short process steps, simplified operational complexity, reduced process hazards, and reduced environmental issues.
在一方面,本文提供了一種製備具有式II的化合物之方法,其中 (式II) R 6-R 10各自獨立地選自氫、鹵素和肼基; 其中R 6-R 10中的至少一個係肼基,該方法包括: I) 形成包含以下的混合物: A) 具有式I的化合物,其中 (式I) R 1-R 5各自獨立地選自氫和鹵素 其中R 1-R 5中的至少一個係鹵素; B) 無機肼衍生物; C) 相轉移催化劑,其中該相轉移催化劑不含季銨相轉移催化劑和冠醚相轉移催化劑; D) 無機鹼或鹽;以及 E) 視需要包含有機溶劑和視需要水的溶劑;以及 II) 使該混合物反應。 In one aspect, provided herein is a method of preparing a compound having formula II, wherein (Formula II) R 6 -R 10 are each independently selected from hydrogen, halogen and hydrazine; wherein at least one of R 6 -R 10 is hydrazine, the method comprising: I) forming a mixture comprising: A) a compound having Formula I, wherein (Formula I) R 1 -R 5 are each independently selected from hydrogen and halogen, wherein at least one of R 1 -R 5 is halogen; B) an inorganic hydrazine derivative; C) a phase transfer catalyst, wherein the phase transfer catalyst does not contain a quaternary ammonium phase transfer catalyst and a crown ether phase transfer catalyst; D) an inorganic base or salt; and E) a solvent optionally comprising an organic solvent and optionally water; and II) reacting the mixture.
如本文所使用的,術語「包含(comprises)」、「包含(comprising)」、「包括(includes)」、「包括(including)」、「具有(has)」、「具有(having)」、「含有(contains)」、「含有(containing)」、「特徵為(characterized by)」或其任何其他變體,旨在涵蓋非排他性包括,受到明確指出的任何限制。例如,包含一系列要素的組成物、混合物、製程或方法不一定僅限於那些要素,而是可以包括未明確列出的其他要素或此類組成物、混合物、製程或方法固有的其他要素。As used herein, the terms "comprises," "comprising," "includes," "including," "has," "having," "contains," "containing," "characterized by," or any other variation thereof, are intended to cover a non-exclusive inclusion, subject to any limitation expressly stated. For example, a composition, mixture, process, or method that comprises a list of elements is not necessarily limited to those elements but may include other elements not expressly listed or inherent to such composition, mixture, process, or method.
連接短語「由……組成」排除任何未指出的要素、步驟或成分。如果在請求項中,則此短語將使請求項為封閉式,不包括除所述那些外的材料,但與其通常相關的雜質除外。當短語「由……組成」出現在請求項主體的子句中而非緊接前序部分時,該短語僅僅限制該子句中闡述的要素;整體上,該請求項並不排除其他要素。The transitional phrase "consisting of" excludes any unspecified element, step, or ingredient. If in a claim, this phrase renders the claim closed, excluding materials other than those stated, except for impurities normally associated therewith. When the phrase "consisting of" appears in a clause of the body of a claim rather than in the immediate preceding clause, the phrase limits only the elements stated in that clause; the claim as a whole does not exclude other elements.
連接詞「基本上由……組成(consisting essentially of)」用於定義組成物或方法,其包括了字面上所揭露的那些之外的材料、步驟、特徵、組分或要素,前提係該等額外的材料、步驟、特徵、組分或要素不會實質性地影響所要求的發明的基本和新穎特徵。術語「基本上由……組成」居於「包含」和「由……組成」中間。The conjunction "consisting essentially of" is used to define a composition or method that includes materials, steps, features, components, or elements in addition to those literally disclosed, provided that such additional materials, steps, features, components, or elements do not materially affect the basic and novel characteristics of the claimed invention. The term "consisting essentially of" is intermediate between "comprising" and "consisting of."
當發明或其一部分由諸如「包含」之類的開放式術語定義時,應易於理解的是(除非另有說明),該描述應被解釋為還使用了術語「基本上由……組成」或「由……組成」來描述這樣的發明。When an invention or a portion thereof is defined by an open term such as "comprising", it should be readily understood that (unless otherwise indicated) the description should be interpreted as also using the term "consisting essentially of" or "consisting of" to describe such an invention.
此外,除非明確相反地指出,否則「或」係指包含性的或而非排他性的或。例如,條件A或B由以下中任一個滿足:A為真(或存在)且B為假(或不存在)、A為假(或不存在)且B為真(或存在)以及A和B皆為真(或存在)。In addition, unless expressly stated to the contrary, "or" refers to an inclusive or and not to an exclusive or. For example, condition A or B is satisfied by any of the following: A is true (or exists) and B is false (or does not exist), A is false (or does not exist) and B is true (or exists), and both A and B are true (or exist).
另外,在本發明的要素或組分之前的不定冠詞「一個/一種(a和an)」旨在關於該要素或組分的實例(即,出現)數量係非限制性的。因此,「一個/一種(a或an)」應被理解為包括一個/一種或至少一個/一種,並且要素或組分的單數單詞形式也包括複數,除非數字顯然意指單數。In addition, the indefinite articles "a and an" before an element or component of the present invention are intended to be non-restrictive regarding the number of instances (i.e., occurrences) of the element or component. Therefore, "a or an" should be understood to include one or at least one, and the singular form of an element or component also includes the plural unless the number obviously means the singular.
如本文所使用的,術語「約」意指該值的正負10%。As used herein, the term "about" means plus or minus 10% of the value.
如本文所使用的,單位「m/m」係指當量重量並且與「eq.」相同。As used herein, the unit "m/m" refers to equivalent weight and is the same as "eq.".
術語「鹵素」,單獨地或在複合詞諸如「鹵代烷基」中,包括氟、氯、溴或碘。此外,當用在複合詞諸如「鹵代烷基」中時,所述烷基可被可以是相同或不同的鹵素原子部分取代或完全取代。The term "halogen", alone or in compound words such as "haloalkyl", includes fluorine, chlorine, bromine or iodine. Furthermore, when used in compound words such as "haloalkyl", the alkyl group may be partially or fully substituted by halogen atoms which may be the same or different.
當基團含有可以是氫的取代基,例如R 4時,則當將該取代基視為氫時,認為這等同於所述基團係未取代的。 When a group contains a substituent which may be hydrogen, such as R 4 , then when the substituent is regarded as hydrogen, this is considered equivalent to the group being unsubstituted.
術語「肼基」包括但不限於包含肼基鍵(-HN-NH2)的官能基。The term "hydrazino" includes but is not limited to functional groups containing a hydrazino bond (-HN-NH2).
本發明的某些化合物可以一種或多種立體異構物存在。各種立體異構物包括鏡像異構物、非鏡像異構物、阻轉異構物和幾何異構物。熟悉該項技術者將理解,一種立體異構物當相對於一種或多種其他立體異構物富集時,或當與一種或多種其他立體異構物分離時,可能更有活性和/或可能表現出有益的效果。另外,熟悉該項技術者知道如何分離、富集和/或選擇性地製備所述立體異構物。Certain compounds of the present invention may exist as one or more stereoisomers. Various stereoisomers include mirror image isomers, non-mirror image isomers, atropisomers and geometric isomers. Those skilled in the art will appreciate that one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to one or more other stereoisomers, or when separated from one or more other stereoisomers. In addition, those skilled in the art know how to separate, enrich and/or selectively prepare the stereoisomers.
本揭露之實施方式包括:The implementation methods of this disclosure include:
實施方式1. 一種製備具有式II的化合物之方法,其中, (式II) R 6-R 10各自獨立地選自氫、鹵素和肼基; 其中R 6-R 10中的至少一個係肼基,該方法包括: I) 形成包含以下的混合物: A) 具有式I的化合物,其中 (式I) R 1-R 5各自獨立地選自氫和鹵素 其中R 1-R 5中的至少一個係鹵素; B) 無機肼衍生物; C) 相轉移催化劑,其中該相轉移催化劑不含季銨相轉移催化劑和冠醚相轉移催化劑; D) 無機鹼或鹽;以及 E) 視需要包含有機溶劑和視需要水的溶劑;以及 II) 使該混合物反應。 Embodiment 1. A method for preparing a compound of formula II, wherein: (Formula II) R 6 -R 10 are each independently selected from hydrogen, halogen and hydrazine; wherein at least one of R 6 -R 10 is hydrazine, the method comprising: I) forming a mixture comprising: A) a compound having Formula I, wherein (Formula I) R 1 -R 5 are each independently selected from hydrogen and halogen, wherein at least one of R 1 -R 5 is halogen; B) an inorganic hydrazine derivative; C) a phase transfer catalyst, wherein the phase transfer catalyst does not contain a quaternary ammonium phase transfer catalyst and a crown ether phase transfer catalyst; D) an inorganic base or salt; and E) a solvent optionally comprising an organic solvent and optionally water; and II) reacting the mixture.
實施方式2. 如實施方式1所述之方法,其中該混合物進一步包含水性溶劑,其包含水。Embodiment 2. The method as described in Embodiment 1, wherein the mixture further comprises an aqueous solvent comprising water.
實施方式3. 如實施方式2所述之方法,其中該水性溶劑係水。Embodiment 3. The method as described in Embodiment 2, wherein the aqueous solvent is water.
實施方式4. 如實施方式1所述之方法,其中該無機肼衍生物選自水性肼、水合肼、肼鹽及其組合。Embodiment 4. The method as described in Embodiment 1, wherein the inorganic hydrazine derivative is selected from aqueous hydrazine, hydrazine hydrate, hydrazine salts and combinations thereof.
實施方式5. 如實施方式4所述之方法,其中該無機肼衍生物係包含一水合肼的水性肼。Embodiment 5. The method as described in Embodiment 4, wherein the inorganic hydrazine derivative is aqueous hydrazine comprising hydrazine monohydrate.
實施方式6.如實施方式1所述之方法,其中該無機肼衍生物以大於約1 m/m的量存在。Embodiment 6. The method of embodiment 1, wherein the inorganic hydrazine derivative is present in an amount greater than about 1 m/m.
實施方式7. 如實施方式1所述之方法,其中該相轉移催化劑選自醚、環醚、直鏈醚、支鏈醚、月桂基醚、聚氧乙烯月桂醚、苯基醚、二醇、包含從400至1000範圍內的數量的乙二醇單元的聚乙二醇、酯、脫水山梨糖醇酯、聚氧乙烯脫水山梨糖醇酯、羧酸、飽和或不飽和脂肪酸、飽和或不飽和C 12至C 20脂肪酸、有機硫化合物、有機硫酸鹽、及其組合。 Embodiment 7. The method as described in embodiment 1, wherein the phase transfer catalyst is selected from ethers, cyclic ethers, linear ethers, branched ethers, lauryl ethers, polyoxyethylene lauryl ethers, phenyl ethers, glycols, polyethylene glycols containing ethylene glycol units in an amount ranging from 400 to 1000, esters, sorbitan esters, polyoxyethylene sorbitan esters, carboxylic acids, saturated or unsaturated fatty acids, saturated or unsaturated C12 to C20 fatty acids, organic sulfur compounds, organic sulfates, and combinations thereof.
實施方式8. 如實施方式1所述之方法,其中該相轉移催化劑選自聚乙二醇十二烷基醚(Brij® 30)、聚氧乙烯辛基苯基醚(Triton® X-100)、聚乙二醇(PEG)600、脫水山梨糖醇單月桂酸酯(SPAN® 20)、脫水山梨糖醇三硬酯酸酯(SPAN® 65)、聚氧乙烯二醇脫水山梨糖醇單月桂酸酯(Tween® 20)、聚氧乙烯脫水山梨糖醇三油酸酯(Tween® 85)、乙酸、硬脂酸、月桂酸、棕櫚酸、十二烷基硫酸鈉、及其組合。Embodiment 8. The method as described in embodiment 1, wherein the phase transfer catalyst is selected from polyethylene glycol dodecyl ether (Brij® 30), polyoxyethylene octylphenyl ether (Triton® X-100), polyethylene glycol (PEG) 600, sorbitan monolaurate (SPAN® 20), sorbitan tristearate (SPAN® 65), polyoxyethylene glycol sorbitan monolaurate (Tween® 20), polyoxyethylene sorbitan trioleate (Tween® 85), acetic acid, stearic acid, lauric acid, palmitic acid, sodium lauryl sulfate, and combinations thereof.
實施方式9. 如實施方式1所述之方法,其中該相轉移催化劑係可生物降解的。Embodiment 9. The method as described in Embodiment 1, wherein the phase transfer catalyst is biodegradable.
實施方式10. 如實施方式1所述之方法,其中該相轉移催化劑係非離子相轉移催化劑。Embodiment 10. The method as described in Embodiment 1, wherein the phase transfer catalyst is a non-ionic phase transfer catalyst.
實施方式11. 如實施方式1所述之方法,其中該相轉移催化劑以從約0.1 wt.%至約5 wt.%的量存在於該混合物中。Embodiment 11. The method of embodiment 1, wherein the phase transfer catalyst is present in the mixture in an amount from about 0.1 wt.% to about 5 wt.%.
實施方式12. 如實施方式1所述之方法,其中該無機鹼選自氫氧化鈉、氫氧化鉀、碳酸鈉、碳酸鉀、粉狀碳酸鉀(400目)、碳酸氫鉀、碳酸氫鈉、磷酸氫二鉀、磷酸三鉀、磷酸氫二鈉、磷酸三鈉、甲醇鈉、三級丁醇鉀及其組合。Embodiment 12. The method as described in Embodiment 1, wherein the inorganic base is selected from sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, powdered potassium carbonate (400 mesh), potassium bicarbonate, sodium bicarbonate, dipotassium hydrogen phosphate, tripotassium phosphate, disodium hydrogen phosphate, trisodium phosphate, sodium methoxide, potassium tertiary butoxide and combinations thereof.
實施方式13. 如實施方式9所述之方法,其中該無機鹼係碳酸鉀。Embodiment 13. The method as described in Embodiment 9, wherein the inorganic base is potassium carbonate.
實施方式14. 如實施方式1所述之方法,其中該鹽選自硫酸鈉、硫酸鉀、氯化鈉、氯化鉀、及其組合。Embodiment 14. The method as described in Embodiment 1, wherein the salt is selected from sodium sulfate, potassium sulfate, sodium chloride, potassium chloride, and combinations thereof.
實施方式15. 如實施方式1所述之方法,其中該有機溶劑選自甲醇、乙醇、丙醇、異丙醇、正丁醇、三級丁醇、庚烷、甲苯、正辛烷及其組合。Embodiment 15. The method as described in Embodiment 1, wherein the organic solvent is selected from methanol, ethanol, propanol, isopropanol, n-butanol, tertiary butanol, heptane, toluene, n-octane and combinations thereof.
實施方式16. 如實施方式1所述之方法,其中該混合物基本上不含有機溶劑。Embodiment 16. The method according to embodiment 1, wherein the mixture is substantially free of organic solvent.
實施方式17. 如實施方式1所述之方法,其中該具有式I的化合物選自2-氯吡啶、2,3-二氯吡啶、2,6-二氯吡啶及其組合。Embodiment 17. The method according to embodiment 1, wherein the compound having formula I is selected from 2-chloropyridine, 2,3-dichloropyridine, 2,6-dichloropyridine and combinations thereof.
實施方式18. 如實施方式1所述之方法,其中該具有式II的化合物選自2-肼基吡啶、(3-氯-2-吡啶基)肼、(6-氯-2-吡啶基)肼及其組合。Embodiment 18. The method according to embodiment 1, wherein the compound of formula II is selected from 2-hydrazinopyridine, (3-chloro-2-pyridyl)hydrazine, (6-chloro-2-pyridyl)hydrazine and combinations thereof.
實施方式19. 如實施方式1所述之方法,其中使該混合物反應的該方法步驟在約90°C至約130°C範圍內的溫度下發生。Embodiment 19. The method of embodiment 1, wherein the method step of reacting the mixture occurs at a temperature in the range of about 90°C to about 130°C.
實施方式20. 如實施方式1所述之方法,其中使該混合物反應的該方法步驟在小於約50小時的反應時間期間發生。Embodiment 20. The method of embodiment 1, wherein the method step of reacting the mixture occurs during a reaction time of less than about 50 hours.
實施方式21. 如實施方式1所述之方法,其中使該混合物反應的該方法步驟在約1.0332 kg/cm 2至約5 kg/cm 2範圍內的壓力下發生。 Embodiment 21. The method of embodiment 1, wherein the method step of reacting the mixture occurs under a pressure in the range of about 1.0332 kg/cm 2 to about 5 kg/cm 2 .
在一個方面,根據由方案1表示之方法製備具有式II的化合物。R基團如本揭露中的任何地方所定義。 方案1. In one aspect, a compound having Formula II is prepared according to the method represented by Scheme 1. The R group is as defined anywhere in this disclosure. Scheme 1.
該方面包括將具有式I的化合物、無機肼衍生物、不含季銨相轉移催化劑和冠醚相轉移催化劑的相轉移催化劑、無機鹼或鹽、以及視需要包含有機溶劑和視需要水的溶劑混合,並使混合物反應。This aspect comprises mixing a compound having formula I, an inorganic hydrazine derivative, a phase transfer catalyst free of quaternary ammonium phase transfer catalyst and crown ether phase transfer catalyst, an inorganic base or salt, and a solvent comprising an organic solvent and water as needed, and reacting the mixture.
在一個實施方式中,混合物進一步包含水性溶劑,其包含水。在另一個實施方式中,混合物進一步包含水。In one embodiment, the mixture further comprises an aqueous solvent comprising water. In another embodiment, the mixture further comprises water.
在一個實施方式中,無機肼衍生物選自水性肼、水合肼、肼鹽及其組合。在一個實施方式中,水性肼包括一水合肼。在一個實施方式中,無機肼衍生物係具有在約30%至約64%範圍內的濃度的肼水溶液。在一個實施方式中,無機肼衍生物係具有在約30%至約51%範圍內的濃度的肼水溶液。在一個實施方式中,無機肼衍生物以大於1 m/m、大於2 m/m、大於3 m/m、大於5 m/m或大於10 m/m;或從約1 m/m至約10 m/m,或從約1 m/m至約3 m/m、從約2 m/m至約5 m/m,或從約3 m/m至約10 m/m的量存在於混合物中。In one embodiment, the inorganic hydrazine derivative is selected from aqueous hydrazine, hydrazine hydrate, hydrazine salts and combinations thereof. In one embodiment, the aqueous hydrazine comprises hydrazine monohydrate. In one embodiment, the inorganic hydrazine derivative is an aqueous solution of hydrazine having a concentration in the range of about 30% to about 64%. In one embodiment, the inorganic hydrazine derivative is an aqueous solution of hydrazine having a concentration in the range of about 30% to about 51%. In one embodiment, the inorganic hydrazine derivative is present in the mixture in an amount greater than 1 m/m, greater than 2 m/m, greater than 3 m/m, greater than 5 m/m or greater than 10 m/m; or from about 1 m/m to about 10 m/m, or from about 1 m/m to about 3 m/m, from about 2 m/m to about 5 m/m, or from about 3 m/m to about 10 m/m.
相轉移催化劑不含季銨相轉移催化劑和冠醚相轉移催化劑。在一個實施方式中,相轉移催化劑不含不可生物降解的相轉移催化劑。在一個實施方式中,相轉移催化劑係可生物降解的。The phase transfer catalyst does not contain quaternary ammonium phase transfer catalyst and crown ether phase transfer catalyst. In one embodiment, the phase transfer catalyst does not contain non-biodegradable phase transfer catalyst. In one embodiment, the phase transfer catalyst is biodegradable.
在一個實施方式中,相轉移催化劑選自醚、環醚、直鏈醚、支鏈醚、月桂基醚、聚氧乙烯月桂醚、苯基醚、二醇、包含從400至1000範圍內的數量的乙二醇單元的聚乙二醇(PEG)、酯、脫水山梨糖醇酯、聚氧乙烯脫水山梨糖醇酯、羧酸、飽和或不飽和脂肪酸、飽和或不飽和C 12至C 20脂肪酸、有機硫化合物、有機硫酸鹽、及其組合。在一個實施方式中,相轉移催化劑選自聚乙二醇十二烷基醚(Brij® 30)、聚氧乙烯辛基苯基醚(Triton® X-100)、聚乙二醇(PEG)600、脫水山梨糖醇單月桂酸酯(SPAN® 20)、脫水山梨糖醇三硬酯酸酯(SPAN® 65)、聚氧乙烯二醇脫水山梨糖醇單月桂酸酯(Tween® 20)、聚氧乙烯脫水山梨糖醇三油酸酯(Tween® 85)、乙酸、硬脂酸、月桂酸、棕櫚酸、十二烷基硫酸鈉、及其組合。在一個實施方式中,相轉移催化劑係非離子相轉移催化劑。在一個實施方式中,相轉移催化劑以從約0.1 wt.%至約5 wt.%的量存在於該混合物中。在一個實施方式中,相轉移催化劑以從約0.1 wt.%至約3 wt.%的量存在於該混合物中。 In one embodiment, the phase transfer catalyst is selected from ethers, cyclic ethers, linear ethers, branched ethers, lauryl ethers, polyoxyethylene lauryl ethers, phenyl ethers, glycols, polyethylene glycols (PEG) containing ethylene glycol units in an amount ranging from 400 to 1000, esters, sorbitan esters, polyoxyethylene sorbitan esters, carboxylic acids, saturated or unsaturated fatty acids, saturated or unsaturated C12 to C20 fatty acids, organic sulfur compounds, organic sulfates, and combinations thereof. In one embodiment, the phase transfer catalyst is selected from polyethylene glycol lauryl ether (Brij® 30), polyoxyethylene octylphenyl ether (Triton® X-100), polyethylene glycol (PEG) 600, sorbitan monolaurate (SPAN® 20), sorbitan tristearate (SPAN® 65), polyoxyethylene glycol sorbitan monolaurate (Tween® 20), polyoxyethylene sorbitan trioleate (Tween® 85), acetic acid, stearic acid, lauric acid, palmitic acid, sodium dodecyl sulfate, and combinations thereof. In one embodiment, the phase transfer catalyst is a nonionic phase transfer catalyst. In one embodiment, the phase transfer catalyst is present in the mixture in an amount from about 0.1 wt.% to about 5 wt.%. In one embodiment, the phase transfer catalyst is present in the mixture in an amount from about 0.1 wt.% to about 3 wt.%.
在一個實施方式中,無機鹼選自氫氧化鈉、氫氧化鉀、碳酸鈉、碳酸鉀、粉狀碳酸鉀(400目)、碳酸氫鉀、碳酸氫鈉、磷酸氫二鉀、磷酸三鉀、磷酸氫二鈉、磷酸三鈉、甲醇鈉、三級丁醇鉀及其組合。在一個實施方式中,無機鹼係碳酸鉀。在一個實施方式中,無機鹼以從約0.1 m/m至約2 m/m的量存在於混合物中。在另一個實施方式中,無機鹼以從約0.25 m/m至約1.5 m/m的量存在於混合物中。In one embodiment, the inorganic base is selected from sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, powdered potassium carbonate (400 mesh), potassium bicarbonate, sodium bicarbonate, dipotassium hydrogen phosphate, tripotassium phosphate, disodium hydrogen phosphate, trisodium phosphate, sodium methoxide, potassium tertiary butoxide, and combinations thereof. In one embodiment, the inorganic base is potassium carbonate. In one embodiment, the inorganic base is present in the mixture in an amount from about 0.1 m/m to about 2 m/m. In another embodiment, the inorganic base is present in the mixture in an amount from about 0.25 m/m to about 1.5 m/m.
在一個實施方式中,鹽係無機鹽。在另一個實施方式中,鹽選自硫酸鈉、硫酸鉀、氯化鈉、氯化鉀、及其組合。In one embodiment, the salt is an inorganic salt. In another embodiment, the salt is selected from sodium sulfate, potassium sulfate, sodium chloride, potassium chloride, and combinations thereof.
溶劑包含有機溶劑和視需要水。在一個實施方式中,溶劑包含有機溶劑和水。在另一個實施方式中,溶劑基本上不含水。在另一個實施方式中,溶劑中不存在水。在一個實施方式中,有機溶劑選自甲醇、乙醇、丙醇、異丙醇、正丁醇、三級丁醇、庚烷、甲苯、正辛烷、及其組合。在另一個實施方式中,混合物基本上不含有機溶劑。在另一個實施方式中,混合物中不存在有機溶劑。The solvent comprises an organic solvent and optionally water. In one embodiment, the solvent comprises an organic solvent and water. In another embodiment, the solvent is substantially free of water. In another embodiment, water is not present in the solvent. In one embodiment, the organic solvent is selected from methanol, ethanol, propanol, isopropanol, n-butanol, tertiary butanol, heptane, toluene, n-octane, and combinations thereof. In another embodiment, the mixture is substantially free of organic solvent. In another embodiment, organic solvent is not present in the mixture.
在一個實施方式中,具有式I的化合物選自2-氯吡啶、2,3-二氯吡啶、2,6-二氯吡啶及其組合。In one embodiment, the compound having Formula I is selected from 2-chloropyridine, 2,3-dichloropyridine, 2,6-dichloropyridine, and combinations thereof.
在一個實施方式中,具有式II的化合物選自2-肼基吡啶、(3-氯-2-吡啶基)肼、(6-氯-2-吡啶基)肼及其組合。In one embodiment, the compound having Formula II is selected from 2-hydrazinopyridine, (3-chloro-2-pyridinyl)hydrazine, (6-chloro-2-pyridinyl)hydrazine, and combinations thereof.
在一個實施方式中,使混合物反應之方法步驟在高溫下發生。在另一個實施方式中,使混合物反應之方法步驟在約90°C至約130°C範圍內的溫度下發生。In one embodiment, the method step of reacting the mixture occurs at an elevated temperature. In another embodiment, the method step of reacting the mixture occurs at a temperature in the range of about 90°C to about 130°C.
在一個實施方式中,使混合物反應之方法步驟在小於約50小時的反應時間期間發生。在另一個實施方式中,使混合物反應之方法步驟大部分在約10小時內完成。In one embodiment, the method step of reacting the mixture occurs during a reaction time of less than about 50 hours. In another embodiment, the method step of reacting the mixture is mostly completed within about 10 hours.
在一個實施方式中,使混合物反應之方法步驟在約1.0332 kg/cm 2至約10 kg/cm 2範圍內的壓力下發生。在另一個實施方式中,使混合物反應之方法步驟在約1.0332 kg/cm 2至約5 kg/cm 2範圍內的壓力下發生。 In one embodiment, the process step of reacting the mixture occurs at a pressure in the range of about 1.0332 kg/cm 2 to about 10 kg/cm 2. In another embodiment, the process step of reacting the mixture occurs at a pressure in the range of about 1.0332 kg/cm 2 to about 5 kg/cm 2 .
在一方面,根據由方案2表示之方法製備(3-氯-2-吡啶基)肼。 方案2. In one aspect, (3-chloro-2-pyridyl)hydrazine is prepared according to the method represented by Scheme 2. Scheme 2.
在一方面,根據由方案3表示之方法製備2-肼基吡啶。 方案3. 實例 In one aspect, 2-hydrazinopyridine is prepared according to the method represented by Scheme 3. Scheme 3. Examples
無需進一步詳細闡述,據信熟悉該項技術者使用先前描述可以最大程度地利用本發明。因此,以下實例應被解釋為僅是說明性的,並且不以任何方式限制本揭露。以下實例的起始材料可能不一定係藉由特定的製備運行來製備,其程式在其他實例中描述。還應理解,本文列舉的任何數值範圍包括從下限值到上限值的所有值。例如,如果將範圍指定為10-50,則預期本說明書中明確地列舉了諸如12-30、20-40或30-50等值。該等僅是具體意圖的實例,並在所列舉的最低值與最高值之間(並且包括其最低值和最高值)的數值的所有可能的組合將被認為在本申請中清楚地陳述。Without further elaboration, it is believed that those familiar with the art can utilize the present invention to the greatest extent using the previous description. Therefore, the following examples should be interpreted as being illustrative only and not limiting the present disclosure in any way. The starting materials of the following examples may not necessarily be prepared by a specific preparation run, the procedures of which are described in other examples. It should also be understood that any numerical ranges listed herein include all values from the lower limit to the upper limit. For example, if a range is specified as 10-50, it is expected that values such as 12-30, 20-40 or 30-50 are explicitly listed in this specification. These are only examples of specific intent, and all possible combinations of numerical values between (and including the lowest and highest values) listed will be considered to be clearly stated in this application.
實例1. 非離子表面活性劑作為相轉移催化劑。Example 1. Nonionic surfactants as phase transfer catalysts.
在環境溫度下,將137 g(0.5 m/m)K 2CO 3添加到300 g(1.986莫耳)2,3-二氯吡啶、248 g(2 m/m)水合肼(80%)、和3 g Tween® 85(% w/w wrt 2,3-二氯吡啶)的混合物中。作為參考,80%水合肼相當於51%水性肼。將反應混合物在1小時內加熱至110°C-120°C,並在回流溫度下保持27小時。由LC A%監測的反應示出97.7% (3-氯-2-吡啶基)肼和0.23% 2,3-二氯吡啶。使反應物質冷卻至80°C,並用300 g水稀釋,並進一步冷卻至25°C-30°C。藉由過濾從反應物質中分離沈澱物(3-氯-2-吡啶基)肼,用600 g水洗滌濕濾餅,並在60°C-65°C、100-150托真空下乾燥10-12小時,直到獲得恒定重量。 137 g (0.5 m/m) K 2 CO 3 was added to a mixture of 300 g (1.986 mol) 2,3-dichloropyridine, 248 g (2 m/m) hydrazine hydrate (80%), and 3 g Tween® 85 (% w/w wrt 2,3-dichloropyridine) at ambient temperature. For reference, 80% hydrazine hydrate is equivalent to 51% aqueous hydrazine. The reaction mixture was heated to 110°C-120°C in 1 hour and maintained at reflux temperature for 27 hours. The reaction monitored by LC A% showed 97.7% (3-chloro-2-pyridyl)hydrazine and 0.23% 2,3-dichloropyridine. The reaction mass was cooled to 80°C and diluted with 300 g water and further cooled to 25°C-30°C. The precipitate (3-chloro-2-pyridyl)hydrazine was separated from the reaction mass by filtration, the wet filter cake was washed with 600 g of water and dried at 60-65° C. under 100-150 torr vacuum for 10-12 hours until a constant weight was obtained.
[表1.] 輸出摘要。
實例2. 使用80%水合肼的相催化劑篩選。Example 2. Phase catalyst screening using 80% hydrazine hydrate.
篩選各種相催化劑以確定其在根據本揭露之反應中的相對有效性。使用實例1之方法用表2中示出的催化劑和反應物量篩選每種相催化劑。結果在表3中示出。在兩個表中,CE代表對比實例,並且IE代表本發明實例。Various phase catalysts were screened to determine their relative effectiveness in reactions according to the present disclosure. Each phase catalyst was screened using the method of Example 1 with the catalyst and reactant amounts shown in Table 2. The results are shown in Table 3. In both tables, CE represents comparative examples, and IE represents inventive examples.
[表2.] 使用80%水合肼的相催化劑篩選。
[表3.] 使用80%水合肼的相催化劑篩選。
該實例證明了在季銨相轉移催化劑和冠醚相轉移催化劑與本發明相轉移催化劑之間可比較的純度和產率。This example demonstrates comparable purity and yield between quaternary ammonium phase transfer catalysts and crown ether phase transfer catalysts and the phase transfer catalysts of the present invention.
實例3. 使用100%水合肼的相催化劑篩選。Example 3. Phase catalyst screening using 100% hydrazine hydrate.
篩選各種相催化劑以確定其在根據本揭露之反應中的相對有效性。使用實例1之方法用表4中示出的催化劑和反應物量篩選每種相催化劑。反應5小時之後的結果在表5中示出,並且反應10小時後的結果在表6中示出。在所有表中,CE代表對比實例,並且IE代表發明實例。Various phase catalysts were screened to determine their relative effectiveness in the reaction according to the present disclosure. Each phase catalyst was screened using the method of Example 1 with the catalyst and reactant amounts shown in Table 4. The results after 5 hours of reaction are shown in Table 5, and the results after 10 hours of reaction are shown in Table 6. In all tables, CE represents comparative examples, and IE represents inventive examples.
[表4.] 使用100%水合肼的相催化劑篩選。
[表5.] 在5小時後使用100%水合肼的相催化劑篩選。
[表6.] 在10小時後使用100%水合肼的相催化劑篩選。
該實例證明了在季銨相轉移催化劑和冠醚相轉移催化劑與本發明相轉移催化劑之間可比較的純度和隨時間的產率。This example demonstrates comparable purity and yield over time between quaternary ammonium phase transfer catalysts and crown ether phase transfer catalysts and the phase transfer catalysts of the present invention.
該書面描述使用實例來說明本揭露,包括最佳模式,並且還使任何熟悉該項技術者能夠實踐本揭露,包括製造和使用任何裝置或系統以及執行任何合併之方法。本揭露之可專利範圍由請求項限定,並且可以包括熟悉該項技術者想到的其他實例。如果這樣的其他實例具有與請求項的字面語言沒有區別的結構要素,或者如果它們包括與請求項的字面語言沒有實質性區別的等效結構要素,則它們旨在該等請求項的範圍內。This written description uses examples to illustrate the disclosure, including the best mode, and also to enable any person skilled in the art to practice the disclosure, including making and using any devices or systems and performing any incorporated methods. The patentable scope of the disclosure is defined by the claims, and may include other examples that occur to those skilled in the art. Such other examples are intended to be within the scope of the claims if they have structural elements that do not differ from the literal language of the claims, or if they include equivalent structural elements that do not differ substantially from the literal language of the claims.
無without
無without
無without
Claims (21)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263404999P | 2022-09-09 | 2022-09-09 | |
US63/404,999 | 2022-09-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202419442A true TW202419442A (en) | 2024-05-16 |
Family
ID=88237993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW112130038A TW202419442A (en) | 2022-09-09 | 2023-08-10 | New processes for synthesis of (3-chloro-2-pyridyl)hydrazine |
Country Status (2)
Country | Link |
---|---|
TW (1) | TW202419442A (en) |
WO (1) | WO2024054476A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05002123A (en) * | 2002-08-30 | 2005-06-06 | Pfizer Prod Inc | Novel processes and intermediates for preparing triazolo-pyridines. |
CN106045876B (en) * | 2016-06-07 | 2018-02-09 | 四川福思达生物技术开发有限责任公司 | A kind of synthetic method of p-hydrochloride |
TW202120478A (en) * | 2019-11-22 | 2021-06-01 | 美商富曼西公司 | New processes for synthesis of (3-chloro-2-pyridyl)hydrazine |
-
2023
- 2023-08-10 TW TW112130038A patent/TW202419442A/en unknown
- 2023-09-06 WO PCT/US2023/032047 patent/WO2024054476A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2024054476A1 (en) | 2024-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20120099039A (en) | Method for producing dabigatran etexilate | |
TW200927716A (en) | Process and intermediates for preparing integrase inhibitors | |
CN105566215B (en) | A kind of Rui Gefeini preparation method | |
EP2646431B1 (en) | A process for the preparation of pazopanib using novel intermediate | |
WO2021102393A1 (en) | Process for the synthesis of (3-chloro-2-pyridyl)hydrazine | |
TW202419442A (en) | New processes for synthesis of (3-chloro-2-pyridyl)hydrazine | |
KR102559870B1 (en) | Method for preparing carbamate compound | |
JP6816274B2 (en) | (S) Method for producing -N1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride | |
CN110023316A (en) | Prepare the chemical method of imidazo pyrrolidinone derivatives and its intermediate | |
KR20180105450A (en) | A Method of preparing Fimarsartan choline salt and hydrate thereof | |
CA2530964A1 (en) | Crystalline form of rabeprazole sodium | |
JP5740042B2 (en) | Compound, method for producing compound, and method for purifying compound | |
KR101694262B1 (en) | Process for preparing crystalline forms of silodosin | |
JP4790901B2 (en) | Process for producing 4-amino-5-cyanoimidazole derivative and its intermediate | |
WO2005037823A1 (en) | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazol-4-one or its salt | |
TWI879818B (en) | Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid | |
JP4879907B2 (en) | Process for producing phenyl 2-pyrimidinyl ketones and novel intermediates thereof | |
KR101733084B1 (en) | Process for preparing crystalline forms of silodosin | |
CN115605470B (en) | Method for preparing androgen receptor antagonist and intermediate thereof | |
JP4067262B2 (en) | Method for producing disubstituted nitroguanidine derivatives | |
EA046889B1 (en) | METHODS FOR OBTAINING 5-BROMO-2-(3-CHLOROPYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | |
CN116768972A (en) | Preparation method of carfilzomib intermediate | |
EA046640B1 (en) | METHOD AND INTERMEDIATE COMPOUND FOR OBTAINING OXETAN-2-YLMETHANAMINE | |
CN118679153A (en) | Process for preparing 3-bromo-1- (3-chloropyridin-2-yl) -4, 5-dihydro-1H-pyrazole-5-carboxylic acid ethyl ester | |
CN114650985A (en) | Process for the preparation of 5-bromo-2- (3-chloro-pyridin-2-yl) -2H-pyrazole-3-carboxylic acid |